GC Cell was reborn as joint corporation of Korea’s leading cell therapy companies, GC Green Cross Cell and GC Green Cross Lab Cell, for a new leap forward. GC Cell is leading the business in research and development for cell therapy, immune-oncology, CDMO, bio-logistics, clinical laboratory services, banking, and other related services.

Since 2007, GC Cell has experienced in manufacturing and selling the largest number of cell therapy product, Immuncell-LC, in the world. We have set an example of quality control by receiving an approval on KGMP facilities from MFDS, and produce high-quality biopharmaceuticals with standard hi-tech production facilities.

With this manufacturing experience and acquisition of U.S. CDMO company, BioCentriq, GC Cell will exert the best synergy in the CDMO business sector with a new strategy that encompasses the North American and Asian markets.